6,7-Dihydroxy-3,4-dihydroisoquinoline: A novel inhibitor of nuclear factor-κb and in vitro invasion in murine mammary cancer cells

Chemotherapy

Volumn 55, Issue 3, 2009, Pages 175-182

  Alvarez, Francisco N ^a   Carlson, Louise M ^b   Lindner, Inna ^b   Lee, Kelvin P ^b,c  

^a Pine Crest School   (United States)

^b UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

^c ROSWELL PARK CANCER INSTITUTE   (United States)

Author keywords

Acetophenones; Metastasis; Nuclear factor B; Quantitative structure activity relationship analysis

Indexed keywords

3,4 DIHYDRO 6,7 DIHYDROXYISOQUINOLINE; ACETOPHENONE; ANTIMETASTATIC AGENT; I KAPPA B; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; ISOQUINOLINE DERIVATIVE; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; BREAST CANCER; CANCER INHIBITION; CELL INVASION; CELL PROLIFERATION; CELL SURVIVAL; CONTROLLED STUDY; GEL MOBILITY SHIFT ASSAY; IN VITRO STUDY; METASTASIS; METASTASIS INHIBITION; MOUSE; NONHUMAN; PRIORITY JOURNAL; STRUCTURE ACTIVITY RELATION; WESTERN BLOTTING;

ACETOPHENONES; ANIMALS; ANTINEOPLASTIC AGENTS; ISOQUINOLINES; MAMMARY NEOPLASMS, ANIMAL; MICE; NEOPLASM INVASIVENESS; NF-KAPPA B; SIGNAL TRANSDUCTION; STRUCTURE-ACTIVITY RELATIONSHIP; TUMOR CELLS, CULTURED;

EID: 65449119272     PISSN: 00093157     EISSN: None     Source Type: Journal    
DOI: 10.1159/000215303     Document Type: Article

References (22)

1. Kochanek KD, Murphy SL, Anderson RN, Scott C:Deaths:final data for 2002. Natl Vital Stat Rep 2004;53:1-115.
2. Baeuerle PA, Henkel T:Function and activation of NF-kappa B in the immune system. Annu Rev Immunol 1994;12:141-179.
3. Perkins ND:Integrating cell-signalling pathways with NF-kappaB and IKK function. Nat Rev Mol Cell Biol 2007;8:49-62.
4. Haffner MC, Berlato C, Doppler W:Exploiting our knowledge of NF-kappaB signaling for the treatment of mammary cancer. J Mammary Gland Biol Neoplasia 2006;11:63-73.
5. Fimognari C, Berti F, Nüsse M, Cantelli Forti G, Hrelia P:In vitro antitumor activity of cyanidin-3-O-β-glucopyranoside. Chemotherapy 2005;51:332-335.
6. Thongphasuk P, Stremmel W, Chamulitrat W:Potent direct or TNF-α-promoted anticancer effects of 2,3-dehydrosilybin:comparison study with silybin. Chemotherapy 2008;54:23-30.
7. Lafeber FP, Beukelman CJ, van den Worm E, van Roy JL, Vianen ME, van Roon JA, van Dijk H, Bijlsma JW:Apocynin, a plant-derived, cartilage-saving drug, might be useful in the treatment of rheumatoid arthritis. Rheumatology (Oxford) 1999;38:1088-1093.
8. Stolk J, Rossie W, Djikman JH:Apocynin improves the efficacy of secretory leukocyte protease inhibitor in experimental emphysema. Am J Respir Crit Care Med 1994;150:1628-1631.
9. van den Worm E, Beukelman CJ, van den Berg AJ, Kroes BH, Labadie RP, van Dijk H:Effects of methoxylation of apocynin and analogs on the inhibition of reactive oxygen species production by stimulated human neutrophils. Eur J Pharmacol 2001;433:225-230.
10. Barbieri SS, Cavalca V, Eligini S, Brambilla M, Caiani A, Tremoli E, Colli S:Apocynin prevents cyclooxygenase 2 expression in human monocytes through NADPH oxidase and glutathione redox-dependant mechanisms. Free Radic Biol Med 2004;37:156-165.
11. 't Hart BA, Simons JM, Knaan-Shanzer S, Bakker NP, Labadie RP:Antiarthritic activity of the newly developed neutrophil oxidative burst antagonist apocynin. Free Radic Biol Med 1990;9:127-131.
12. Palmen MJHJ, Beukelman CJ, Mooij RGM, Pena AS, van Rees EP:Anti-inflammatory effect of apocynin, a plant-derived NADPH oxidase antagonist, in acute experimental colitis. Neth J Med 1995;47:A41.
13. Peters EA, Hiltermann JTN, Stolk J:Effect of apocynin on ozone-induced airway hyperresponsiveness to methacholine in asthmatics. Free Radic Biol Med 2001;31:14 4 2 -14 4 7.
14. Lindner I, Kharfan-Dabaja, MA, Ayala E, Kolonias D, Carlson LM, Blazer-Barclay Y, Scherf U, Hnatyszyn JH, Lee KP:Induced dendritic cell differentiation of chronic myeloid leukemia blasts is associated with down-regulation of BCR-ABL. J Immunol 2003;4:1780-1791.
15. Grosso JF, Herbert LM, Owen JL, Lopez DM:MUC1/sec-expressing tumors are rejected in vivo by a T cell-dependent mechanism and secrete high levels of CCL2. J Immunol 2004;173:1721-1730.
16. Dignam JD, Martin PL, Shastry BS, Roeder RG:Eukaryotic gene transcription with purified components. Methods Enzymol 1983;101:582-598.
17. Murakami Y, Hirata A, Ito S, Shoji M, Tanaka S, Yasui T, Machino M, Fujisawa S:Reevaluation of cyclooxygenase-2-inhibiting activity of vanillin and guaiacol in macrophages stimulated with lipopolysaccharide. Anticancer Res 20 07;27:801-807.
18. Riganti C, Costamagna C, Doublier S, Miraglia E, Polimeni M, Bosia A, Ghigo D:The NADPH oxidase inhibitor apocynin induces nitric oxide synthesis via oxidative stress. Toxicol Appl Pharmacol 2008;228:277-285.
19. Xiong X, Liu H, Fu L, Li L, Li J, Luo X, Mei C:Antitumor activity of a new N-substituted thiourea derivative, an EGFR signaling-targeted inhibitor against a panel of human lung cancer cell lines. Chemotherapy 2008;54:463-474.
20. Natarajan K, Singh S, Burke TR, Grunberger D, Aggarwal BB:Caffeic acid phenethyl ester is a potent and specific inhibitor of nuclear transcription factor NF-kappaB. Proc Natl Acad Sci USA 1996;93:9090-9095.
21. Lirdprapamongkol K, Sakurai H, Kawasaki N, Choo M, Saitoh Y, Aozuka Y, Singhirunnusorn P, Ruchirawat S, Svasti J, Saiki I:Vanillin suppresses in vitro invasion and in vivo metastasis of mouse breast cancer cells. Eur J Pharm Sci 2005;25:57-65.
22. Herbert LM, Grosso JF, Dorsey M Jr, Fu T, Keydar I, Cejas MA, Wreschner DH, Smorodinski N, Lopez DM:A unique mucin immunoenhancing peptide with antitumor properties. Cancer Res 2004;21:8077-8084.